127 related articles for article (PubMed ID: 3978249)
1. Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.
Heinonen E; Alanko A; Gröhn P; Rissanen P
Breast Cancer Res Treat; 1985; 5(1):75-80. PubMed ID: 3978249
[TBL] [Abstract][Full Text] [Related]
2. Hormonal treatment of advanced breast cancer. A randomized trial of tamoxifen versus nandrolone decanoate.
Kellokumpu-Lehtinen P; Huovinen R; Johansson R
Cancer; 1987 Nov; 60(10):2376-81. PubMed ID: 3664426
[TBL] [Abstract][Full Text] [Related]
3. Combined tamoxifen and anabolic steroid as primary treatment for breast carcinoma in the elderly.
Pain JA; Wickremesinghe SS; Bradbeer JW
Eur J Surg Oncol; 1990 Jun; 16(3):225-8. PubMed ID: 2347416
[TBL] [Abstract][Full Text] [Related]
4. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
Alanko A; Heinonen E; Scheinin T; Tolppanen EM; Vihko R
Cancer; 1985 Oct; 56(7):1696-700. PubMed ID: 4027900
[TBL] [Abstract][Full Text] [Related]
5. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
[TBL] [Abstract][Full Text] [Related]
6. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.
Flicker L; Hopper JL; Larkins RG; Lichtenstein M; Buirski G; Wark JD
Osteoporos Int; 1997; 7(1):29-35. PubMed ID: 9102059
[TBL] [Abstract][Full Text] [Related]
7. Effects of nandrolone decanoate in NZB/W mice treated concomitantly with maintenance doses of dexamethasone sodium phosphate.
Verheul HA; Deckers GH; Schuurs AH
Int J Immunopharmacol; 1985; 7(2):249-54. PubMed ID: 4008140
[TBL] [Abstract][Full Text] [Related]
8. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.
Bird HA; Burkinshaw L; Pearson D; Atkinson PJ; Leatham PA; Hill J; Raven A; Wright V
Ann Rheum Dis; 1987 Mar; 46(3):237-43. PubMed ID: 3555359
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
Geusens P; Dequeker J; Verstraeten A; Nijs J; Van Holsbeeck M
Maturitas; 1986 Dec; 8(4):281-9. PubMed ID: 3574141
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.
Mouridsen HT; Palshof T; Rose C
Recent Results Cancer Res; 1980; 71():169-77. PubMed ID: 6988913
[TBL] [Abstract][Full Text] [Related]
11. Effect of nandrolone decanoate and 1-alpha-hydroxy-calciferol on patients with vertebral osteoporotic collapse. A double-blind clinical trial.
Lyritis GP; Androulakis C; Magiasis B; Charalambaki Z; Tsakalakos N
Bone Miner; 1994 Dec; 27(3):209-17. PubMed ID: 7696887
[TBL] [Abstract][Full Text] [Related]
12. Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer.
Gundersen S; Kvinnsland S; Lundgren S; Klepp O; Lund E; Børmer O; Høst H
Breast Cancer Res Treat; 1990 Nov; 17(1):45-50. PubMed ID: 2151369
[TBL] [Abstract][Full Text] [Related]
13. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.
Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF
Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363
[TBL] [Abstract][Full Text] [Related]
14. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.
Fisher B; Redmond C; Brown A; Wickerham DL; Wolmark N; Allegra J; Escher G; Lippman M; Savlov E; Wittliff J
J Clin Oncol; 1983 Apr; 1(4):227-41. PubMed ID: 6366135
[TBL] [Abstract][Full Text] [Related]
15. Effects of nandrolone decanoate on bone mass in established osteoporosis.
Passeri M; Pedrazzoni M; Pioli G; Butturini L; Ruys AH; Cortenraad MG
Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
[TBL] [Abstract][Full Text] [Related]
16. Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.
Geusens P
Clin Rheumatol; 1995 Sep; 14 Suppl 3():32-9. PubMed ID: 8846659
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
[TBL] [Abstract][Full Text] [Related]
18. Exercise and supraphysiological dose of nandrolone decanoate increase apoptosis in spermatogenic cells.
Shokri S; Aitken RJ; Abdolvahhabi M; Abolhasani F; Ghasemi FM; Kashani I; Ejtemaeimehr S; Ahmadian S; Minaei B; Naraghi MA; Barbarestani M
Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):324-30. PubMed ID: 20002066
[TBL] [Abstract][Full Text] [Related]
19. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
Need AG; Horowitz M; Walker CJ; Chatterton BE; Chapman IC; Nordin BE
Bone; 1989; 10(1):3-6. PubMed ID: 2736154
[TBL] [Abstract][Full Text] [Related]
20. [Adriamycin, cyclophosphamide, ftorafur and tamoxifen (ACFT) in patients with advanced breast cancer].
Imajo K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Ozeki H; Nagamine D; Shinagawa K; Fukutani H
Gan To Kagaku Ryoho; 1988 Jan; 15(1):121-6. PubMed ID: 3122665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
